| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.435 | 3.308 | 4.407 | 3.851 | 10.957 | 9.720 |
| Total Income - EUR | - | - | - | - | 3.435 | 3.308 | 4.407 | 3.851 | 10.958 | 9.723 |
| Total Expenses - EUR | - | - | - | - | 178 | 281 | 544 | 464 | 3.751 | 2.151 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.257 | 3.027 | 3.863 | 3.387 | 7.207 | 7.572 |
| Net Profit/Loss - EUR | - | - | - | - | 3.154 | 2.930 | 3.734 | 3.274 | 5.806 | 6.585 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nicodim Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 25 | 25 | 23 | 1.258 | 1.482 |
| Current Assets | - | - | - | - | 3.211 | 2.991 | 3.921 | 4.207 | 9.422 | 11.755 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 517 | 586 | 588 | 1.638 | 1.337 |
| Cash | - | - | - | - | 3.211 | 2.474 | 3.335 | 3.619 | 7.784 | 10.418 |
| Shareholders Funds | - | - | - | - | 3.196 | 2.980 | 3.782 | 3.323 | 5.855 | 8.693 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 41 | 36 | 164 | 907 | 4.825 | 4.544 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nicodim Therapy S.r.l.